HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?

Detalles Bibliográficos
Autores principales: Gremese, Elisa, Gasbarrini, Antonio, Ferraccioli, Gianfranco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Treatment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046984/
https://www.ncbi.nlm.nih.gov/pubmed/32098858
http://dx.doi.org/10.1136/rmdopen-2020-001171
_version_ 1783502053874597888
author Gremese, Elisa
Gasbarrini, Antonio
Ferraccioli, Gianfranco
author_facet Gremese, Elisa
Gasbarrini, Antonio
Ferraccioli, Gianfranco
author_sort Gremese, Elisa
collection PubMed
description
format Online
Article
Text
id pubmed-7046984
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70469842020-03-09 HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs? Gremese, Elisa Gasbarrini, Antonio Ferraccioli, Gianfranco RMD Open Treatment BMJ Publishing Group 2020-02-25 /pmc/articles/PMC7046984/ /pubmed/32098858 http://dx.doi.org/10.1136/rmdopen-2020-001171 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Treatment
Gremese, Elisa
Gasbarrini, Antonio
Ferraccioli, Gianfranco
HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title_full HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title_fullStr HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title_full_unstemmed HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title_short HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?
title_sort hbv and targeted synthetic (ts)dmards: what have we learned from bdmards and tsdmards?
topic Treatment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7046984/
https://www.ncbi.nlm.nih.gov/pubmed/32098858
http://dx.doi.org/10.1136/rmdopen-2020-001171
work_keys_str_mv AT gremeseelisa hbvandtargetedsynthetictsdmardswhathavewelearnedfrombdmardsandtsdmards
AT gasbarriniantonio hbvandtargetedsynthetictsdmardswhathavewelearnedfrombdmardsandtsdmards
AT ferraccioligianfranco hbvandtargetedsynthetictsdmardswhathavewelearnedfrombdmardsandtsdmards

Ejemplares similares